Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Apply
Avutometinib & Defactinib
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step